- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '99213'
    - '99214'
    - '99215'
    ndc:
    - 0093-1058
    - 0378-6205
    - 68180-0518
    loinc:
    - 33747-0
  conditions:
    any_of:
    - dx_in_value_set: vs_bph_moderate_severe_2025_09
    - dx_in_value_set: vs_bph_with_luts_2025_09
    all_of:
    - age_gte: 40
    - has_flag: failed_conservative_management
    none_of:
    - has_flag: hypotension
    - has_flag: syncope_history
  logic:
    outcome: PA_REQUIRED
    note: Alpha-blocker therapy for moderate to severe BPH with lower urinary tract
      symptoms
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_urology_bph_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_435927beaa1e
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '99213'
    - '99214'
    - '99215'
    ndc:
    - 0006-0071
    - 0173-0715
    loinc:
    - 33747-0
    - 19195-7
  conditions:
    any_of:
    - dx_in_value_set: vs_bph_enlarged_prostate_2025_09
    - dx_in_value_set: vs_bph_progression_risk_2025_09
    all_of:
    - age_gte: 50
    - has_flag: prostate_volume_gt_40ml
    none_of:
    - has_flag: pregnancy_exposure_risk
  logic:
    outcome: PA_REQUIRED
    note: 5-alpha reductase inhibitor therapy for enlarged prostate with progression
      risk
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_urology_bph_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_ddc5aab09f98
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '52601'
    - '52630'
    loinc:
    - 33747-0
    - 19195-7
  conditions:
    any_of:
    - dx_in_value_set: vs_bph_refractory_medical_2025_09
    - dx_in_value_set: vs_bph_complications_2025_09
    all_of:
    - age_gte: 45
    - has_flag: failed_medical_therapy_6_months
    - has_flag: specialist_evaluation
    none_of:
    - has_flag: active_uti
    - has_flag: bleeding_disorder
  logic:
    outcome: PA_REQUIRED
    note: TURP for medically refractory BPH with complications
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_urology_bph_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_626ba5b4672e
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '52647'
    - '52648'
    - '52649'
    loinc:
    - 33747-0
  conditions:
    any_of:
    - dx_in_value_set: vs_bph_refractory_medical_2025_09
    - dx_in_value_set: vs_bph_anticoagulation_2025_09
    all_of:
    - age_gte: 50
    - has_flag: anticoagulation_therapy
    - has_flag: specialist_evaluation
    none_of:
    - has_flag: active_uti
  logic:
    outcome: PA_REQUIRED
    note: Laser enucleation/vaporization for BPH in patients on anticoagulation
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_urology_bph_2025.pdf
    last_verified_at: '2025-09-11'
    last_updated: '2025-09-11'
  id: rule_47320b9ce414
